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Abstract
As there is increasing evidence that aberrant defensin expression is related to susceptibility for infectious disease and
inflammatory disorders, we sought to determine if copy number of the beta-defensin gene cluster located on chromosome
8p23.1 (DEFB107, 106, 105, 104, 103, DEFB4 and SPAG11), that shows copy number variation as a block, was associated with
susceptibility to otitis media (OM). The gene DEFB103 within this complex encodes human beta defensin-3 (hBD-3), an
antimicrobial peptide (AP) expressed by epithelial cells that line the mammalian airway, important for defense of mucosal
surfaces and previously shown to have bactericidal activity in vitro against multiple human pathogens, including the three
that predominate in OM. To this end, we conducted a retrospective case-control study of 113 OM prone children and 267
controls aged five to sixty months. We identified the copy number of the above defined beta-defensin gene cluster (DEFB-
CN) in each study subject by paralogue ratio assays. The mean DEFB-CN was indistinguishable between subjects classified as
OM prone based on a recent history of multiple episodes of OM and control subjects who had no history of OM (4.460.96
versus 4.461.08, respectively: Odds Ratio [OR]: 1.16 (95% CI: 0.61, 2.20). Despite a lack of direct association, we observed a
statistically significant correlation between DEFB-CN and nasopharyngeal bacterial colonization patterns. Collectively, our
findings suggested that susceptibility to OM might be mediated by genetic variation among individuals, wherein a DEFB-CN
less than 4 exerts a marked influence on the microbiota of the nasopharynx, specifically with regard to colonization by the
three predominant bacterial pathogens of OM.
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Introduction
Otitis media (OM) is one of the most common diseases of
childhood [1]. Accordingly, OM represents the leading indication
for antibiotic prescription [2–4], pediatric surgery under general
anesthesia [5] and deafness in childhood [6]. Costs associated with
management of this disease exceed 5 billion dollars annually in the
United States alone [2,7]. At least 80% of children will have
experienced one or more episodes of OM by age 3 and more than
50% will have $3 episodes [8]. Whereas these statistics show that
OM is common across the population, approximately 10–15% of
children are considered ‘otitis prone’ due to their even greater
incidence of disease [9]. Children that experience $3 episodes
within the past six months or $4 episodes within the past 12
months, with at least 1 episode in the past 6 months are classified
as ‘OM prone’ [10].
There are multiple risk factors associated with OM, including
environmental factors, antecedent viral infection, male gender and
inheritance [11,12]. Indeed, studies on mono- and dizygotic twins
and triplets show a heritability of 57% for acute OM and 72% for
chronic OM, emphasizing the importance of genetic variation in
contributing to the overall susceptibility to OM [13,14]. Impaired
immunity predisposes children to OM. For example, variation in
the immune response genes TNFA, IL6, IL10, TLR4, genes
encoding various surfactant proteins, mannose binding lectin and
immunoglobulins, among others, have been associated with
susceptibility to OM [9,14–16]. These associations are not
unexpected given that the middle ear is protected from bacterial
invasion by multiple mechanisms, including effectors of both
innate and acquired immunity.
One category of innate immune effectors operational in the
middle ear and Eustachian tube are the antimicrobial host defense
peptides, which include the defensin family [17–19]. Defensins are
cationic peptides with immunomodulatory properties and potent
anti-microbial activity against bacteria, viruses, and fungi [17,20].
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One class, the beta-defensins, is secreted by mucosal epithelial cells
that line the airway, including the middle ear [18,21]. Moreover,
human beta-defensin-3 (hBD-3) is expressed in the middle ear
during OM and is bactericidal for all three predominant causative
agents of OM [e.g. nontypeable Haemophilus influenzae (NTHI),
Streptococcus pneumoniae and Moraxella catarrhalis], both in vitro [22]
and in vivo [23]. While expression of hBD-3 is important for
defense against infectious agents, this antimicrobial peptide likely
also plays a key role in maintenance of microbial homeostasis, as
virus-mediated dysregulation of hBD-3 expression results in
augmented colonization of the uppermost airway by NTHI [23].
This increase in bacterial load in the nasopharynx (NP), coincident
with an upper respiratory tract (URT) viral infection, is another
known risk factor for OM [24].
The gene encoding hBD-3 (DEFB103) resides on chromosome
8p23.1 within in a cluster of seven beta-defensin genes that
includes DEFB107, 106, 105, 104, 103, DEFB4 and SPAG11. This
cluster forms a large repeat unit, which is variable in copy number
as a block (DEFB-CN). The copy number variation for this gene
cluster among individuals is usually between 2 and 6, however
copy numbers up to 12 have been documented [25]. Copy
number variation of beta-defensin genes has been linked with
concordant functional expression of specific beta-defensins [26]
and associated with important biological consequences relevant to
disease [17]. An increased DEFB-CN has been associated with
psoriasis [25,27] and chronic obstructive pulmonary disease [28].
Conversely, a reduced DEFB-CN is associated with susceptibility
to celiac disease [29], chronic pancreatitis [30] and necrotizing
enterocolitis [31], possibly as a result of an expected overall deficit
in beta-defensin production. There are conflicting reports on the
association of DEFB-CN with Crohn’s disease [32], with data
supporting either lower [33] or higher [34] DEFB-CN.
The goal of our study was to investigate possible associations
between DEFB-CN and proneness to OM. As such, we sought to
characterize bacterial colonization patterns of the pediatric NP
and determine whether relative DEFB-CN predisposes to differ-
ential composition of the NP microbiota in OM prone children,
relative to the three predominant bacterial pathogens of this highly
prevalent pediatric disease.
Materials and Methods
Ethics Statement
The Institutional Review Board (IRB) at Nationwide Children’s
Hospital approved the study protocol. Informed, written consent
was obtained from the legal guardian of all children prior to
sample collection. Due to the minimally invasive nature of NP
flora collection, participating control subjects were nominally
compensated.
Experimental Design
To participate, children needed to be between 6 months and 5
years of age at the time of recruitment. Control subjects had no
history of recurrent ear infection, no current middle ear or
respiratory tract infection and were not on antibiotic therapy;
those who did not meet these criteria were excluded. Episodic OM
was classified upon evaluation by a physician at Nationwide
Children’s Hospital; Columbus, Ohio. From this group, ‘OM-
prone’ patients were defined as those children who experienced $
three episodes of acute OM within the past six months or $ four
episodes of acute OM within the previous 12 months, with at least
one of these episodes occurring in the previous 6 months [10].
OM-prone children undergoing tympanostomy tube insertion
served as cases for this study. During tube insertion, a blood or
saliva sample was also collected. Blood samples were collected by
venipuncture while the patient was anesthetized, then stored at
280uC until genomic DNA (gDNA) was extracted.
To characterize NP bacterial flora and detect the presence of
specific bacterial pathogens within the middle ear of cases, NP
swabs (CultureSwab plus Amies Gel without Charcoal, BD
Diagnostic Systems) from both nares, and middle ear fluids, when
present, were collected during tympanostomy tube insertion. For
middle ear fluid collection, Juhn Tymp taps (Xomed Treace
Products, Jacksonville, FL; USA) were used. Subject samples were
stored on ice for transport to the clinical microbiology laboratory
for microbe identification.
Control subjects were recruited during either well-child visits to
Close-to-Home Centers of Nationwide Children’s Hospital system
or during random visits to the Center for Science and Industry
(COSI); Columbus, Ohio. At enrollment a blood or saliva sample
was collected for recovery of gDNA and NP swabs were taken via
both nares.
Bacteriological Data
To detect the presence of S. pneumoniae, H. influenzae, or M.
catarrhalis, culture data was obtained following selective plating of
NP swabs and middle ear fluids with incubation overnight at 37uC,
in a humidified atmosphere of 5% CO2. Haemophilus X-V factor
test (Fisher Scientific, CA; USA) was utilized and an isolate was
considered to be H. influenzae if growth was observed between the
two strips. H. influenzae isolates were further characterized as being
nontypeable if non-reactive with specific antibody directed against
capsule types a-f. To identify an isolate as M. catarrhalis, isolates
were subjected to an Mcat disk test (Fisher Scientific, CA; USA),
according to manufacturer’s protocol. S. pneumoniae isolates were
identified via Ox Bial test (Fisher Scientific, CA; USA) according
to supplied instructions. Patients were identified as culture positive
if plating of NP swabs resulted in bacterial growth on one or more
selective media. Once a positive identification was made, isolated
colonies were frozen in a skim milk/15% glycerol solution and
stored at 280uC.
DNA Isolation
Genomic DNA was extracted from either blood or saliva, then
sent as coded samples to U.C. Davis for evaluation. Saliva samples
were collected using Oragene DNA saliva collection kit (DNA
Genotek, Ontario, Canada) according to the manufacturer’s
protocol. Genomic DNA was extracted from peripheral blood
leukocytes using the Qiagen QIAamp DNA Blood Reagent Kit
according to the manufacturer’s protocol. For PCR analysis,
genomic DNA concentrations were quantified by spectrophotom-
etry at 260 nm using a Nanodrop spectrometer then diluted to
10 ng/ml in 50.0 mM Tris buffer (pH 8.0) containing yeast RNA
(20 mg/ml, functioning as a nucleic acid carrier).
Copy Number Determination
Using previously published methods [32,35,36], DEFB-CN was
determined by co-authors (AK and CB) who were blinded as to
case-control status and colonization data. Briefly, the measure-
ment of DEFB-CN utilized three paralogue ratio test (PRT) assays:
i) PRT107A, simultaneously amplifies a locus adjacent to
DEFB107 and an unlinked reference locus on chromosome 11,
ii) HSPD21, amplifies a pseudogene located within the beta-
defensin repeat unit, and an unlinked reference locus on
chromosome 21, and iii) 5del, amplifies a multi-allelic insertion/
deletion (indel) segments (rs5889219) located within the beta-
defensin repeat unit [37]. The ratio of test to reference provided an
accurate estimate of the copy number. The 5del assay is a multi-
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allelic ratio test that provided the closest integer number for gene
copy number when the other two assays were ambiguous. Positive
control DNAs were six samples (C0207, C0088, C0849, C0940,
C0969, and C0913) from the Human Random Control DNA
Panels from European Collection of Cell Cultures (ECACC)
commercially available through Sigma Chemicals [HRC-1
(2 m7 g)], with expected DEFB-CNs of 5, 4, 6, 4, 5, and 3,
respectively. The 96-well assay plates contained randomly
interspersed PRT reactions for reference DNA samples, experi-
mental samples and no template controls.
Using ROX500 standard marker, raw data from the fragment
analysis was analyzed with PeakScanner Software v1.0 (Applied
Biosystems). Data was filtered for product sizes of: 153 and 155 for
PRT107A; 170 and 178 for HSPD21; and 3 potential product
sizes of 123, 125, 127 for 5del. To demonstrate concordance in
duplicate independent assays, each PCR was performed using one
of two different fluorescently labeled primers (NED- or FAM-
labeled for PRT107, HEX- or FAM-labeled for HSPD, HEX- or
FAM-labeled for 5del). Aliquots of all six reaction products were
combined for capillary electrophoresis analysis. The copy number
estimates from the PRT107A and HSPD21 assays were combined
using a maximum-likelihood method, which incorporated a
regression analysis using the gene copy number values from the
reference control DNA assays. The resulting linear regression
calibrated the gene copy number estimates for the experimental
samples, together with an associated significance value reflecting
the confidence for that estimate of gene copy number compared to
any other copy numbers estimate. In cases where the combined
PRT107A and HSPD21 assays returned a non-integer copy
number, the 5del assay data provided two additional gene copy
number estimates that were weighted according to the variability
of all six individual assays [36,37].
Statistical Analysis
Associations between DEFB-CN, case-control status, and
bacterial colonization of the NP, were determined by Fisher’s
exact test and univariate logistic regression with correction for
multiple testing via Tukey’s method for multiple comparisons.
Mean DEFB-CN among cases and controls were compared using
an unpaired, two-tailed t-test. For the purposes of analysis, DEFB-
CN was treated as a categorical variable, where subjects were
placed into one of two distinct groups; subjects having DEFB-CN
#4 or separately, subjects with an observed DEFB-CN .4. Age
was also treated as a categorical variable, with subjects divided into
two groups, those age #24 months and all subjects .24 months of
age comprising a second, distinct group. In all cases, a p-value ,
0.05 was considered statistically significant. All statistical analyses
were performed with GraphPad Prism version 5.0 (GraphPad
Software, La Jolla, CA, USA).
Results
Subject characteristics
A total of 372 children met inclusion criteria (Table 1).
Participants ranged from 6-50 months of age, with a mean of
25.9612.8 months. A total of 113 children were classified as OM
prone whereas 259 subjects served as controls. The mean age
among OM prone subjects was 21.3611.7 months and 27.9612.7
months for controls.
Observed DEFB-CN between OM prone and control
subjects
To quantify DEFB-CN, gDNA extracted from blood or saliva
samples we used three PRT assays, as described in Methods. Of
the 372 enrolled participants, we obtained reliable DEFB-CN
values for 343 (92%). Of these 343 samples, 80 (23%) were whole
blood and 263 (77%) were saliva. We observed a slight difference
in DEFB-CN values derived from gDNA depending on the
biological source of the sample, with overall slightly lower DEFB-
CN detected from whole blood (p,0.05, t-test) (Fig. 1A). We
suspect that this result is driven by a sampling effect: the absence of
rarer high copy number samples in the blood cohort due to the
smaller sample size of this cohort as has been observed in other
studies [38]. However, when stratified by sample type, there were
no significant differences found between OM prone and control
DEFB-CN derived from whole blood (p=0.55, t-test) or saliva
samples (p=0.37, t-test) (Figs. 1B&C).
Among study subjects, DEFB-CN ranged from 2 to 9 copies per
diploid genome (Table 1). The mean DEFB-CN for the entire
cohort was 461.04; for OM prone children 460.96; and for
controls 461.08. The modal DEFB-CN for both groups was 4
copies, as expected [25] (Fig. 2). We observed no significant
difference between mean DEFB-CN between the ‘OM prone’ and
control groups (p.0.05) (Table 1).
Table 1. Subject Demographics.
Variable OM Prone Healthy Control Total Cohort
Subjects N=113 N=259 N=372
Mean DEFB-CN6S.D. (Range) 460.96 (2–9) 461.08 (2–9) 461.04 (2–9)
Mean Age in Months 6S.D. (Range) 21.3611.7 (6–50) 27.9612.7 (6–50) 25.9612.8 (6–50)
Male n (%) 73 (66) 146 (56) 219 (59)
Ethnicity n (%)
African American 14 (12) 10 (4) 24 (6.9)
Asian 1 (0.1) 15 (6) 16 (4)
Caucasian 97 (86) 231 (89) 328 (89)
Hispanic 0 (0) 2 (0.07) 2 (0.05)
Unknown 1 (0.1) 1 (0.03) 2 (0.05)
doi:10.1371/journal.pone.0098269.t001
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Characterization of nasopharyngeal bacterial
colonization patterns between OM prone and control
subjects
NP swabs were used to isolate and identify specific patterns of
bacterial colonization of the NP due to the three predominant
pathogens of OM. Of the 372 participants, 30 (8%) were colonized
with NTHI, M. catarrhalis (Mcat) and S. pneumoniae, concurrently
(Table 2). NTHI was detected in the NP of 101 (27%), S.
pneumoniae in 201 (54%) and Mcat in 143 (41%). Additionally, dual
colonization by NTHI and Mcat was detected in 39 (10%)
subjects; NTHI and S. pneumoniae in 73 subjects (19%) and S.
pneumoniae plus Mcat in 95 subjects (26%). In addition to
colonization by multiple pathogens, among OM prone subjects,
54 (55%) were culture positive for NTHI alone, 51 (36%) were
culture positive for Mcat alone and 77 (38%) were culture positive
for S. pneumoniae alone.
When bacterial colonization patterns were restricted by case-
control status, concurrent colonization by NTHI,M. catarrhalis and
S. pneumoniae differed significantly between OM prone and control
children (68% vs. 32%) p,0.001. Dual colonization by NTHI and
Mcat also differed significantly between OM prone and controls,
wherein 26 (67%) OM prone children were culture positive for
these two organisms, while only 13 (33%) controls exhibited this
same colonization pattern (p,0.001). Likewise, 53 (55%) OM
prone children were culture positive for NTHI versus 43 (45%)
among controls. This finding was also statistically significant (p,
0.001) (Table 2). Interestingly, for colonization by Spn alone, this
patterns was reversed with 124 (62%) of healthy children being
culture positive versus 77 (38%) of OM prone children (p=0.0002).
DEFB-CN and OM proneness are predictors of NP
colonization patterns
To identify variables associated with DEFB-CN and disease
among subjects, we conducted logistic regression analyses of
various subject-level variables within our study cohort. We found
no evidence for a direct statistical association between DEFB-CN
and disease status (p.0.05). Thusly, as the modal DEFB-CN
within our cohort was determined to be 4, we stratified subjects
based upon those with a DEFB-CN$4 versus all other subjects, in
order to identify further associations of interest. When stratified in
this manner, we observed that neither single colonization with
NTHI (p=0.59), Mcat (p=0.52) or S. pneumoniae (p=0.24) was
associated with DEFB-CN status. However, subjects with a DEFB-
Figure 1. Cumulative frequency (percent) distribution of raw
DEFB-CN determined from DNA obtained from blood and
saliva samples. (Panel A) We observed a slightly lower mean DEFB-CN
among gDNA templates isolated from whole blood samples (—&&—)
relative to DEFB-CN estimated from gDNA extracted from saliva
samples (NNNmNNN) (p,0.05, t-test). However, when stratified by sample
type, there were no significant differences found between OM prone
(—&&—) and control (NNNmNNN) DEFB-CN derived from either whole blood
samples (Panel B) (p= 0.55, t-test) or saliva samples (Panel C) (p= 0.37,
t-test).
doi:10.1371/journal.pone.0098269.g001
Figure 2. Cumulative DEFB-CN frequency (percent) distribution
among OM prone and control subjects. The overall distribution of
DEFB-CN did not differ significantly among OM prone (—&&—) or control
(NNNmNNN) study subjects (p.0.05).
doi:10.1371/journal.pone.0098269.g002
NP Colonization Linked to OM Proneness
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CNless than 4 were significantly more likely to be colonized by
NTHI, S. pneumoniae and Mcat concurrently (p=0.03). In addition,
having a DEFB-CN less than 4 significantly increased the
likelihood of dual colonization by NTHI and Mcat (p=0.05), as
well as by S. pneumoniae and Mcat (p=0.03) (Table 3).
To determine if bacterial colonization of the NP was
significantly associated with OM proneness, we additionally
stratified upon this variable and subsequently tested for statistical
significance of NP colonization patterns between OM prone and
control subjects. Concurrent colonization by NTHI, S. pneumoniae
and Mcat was a statistically significant predictor of OM prone case
status (p,0.0001), as was colonization by NTHI alone (p,0.0001).
Further, dual colonization by NTHI and Mcat (p,0.0001) as well
as dual colonization by NTHI and S. pneumoniae (p,0.0001); were
statistically significant predictors of being classified as OM prone.
Neither colonization of the NP by S. pneumoniae (p=0.24) or Mcat
(p=0.25) alone were associated with OM prone case status in our
study (Table 3). Whereas being male was not associated with OM
prone case status (p=0.17), being #24 months of age was
associated with such status (p,0.0001).
Discussion
Frequent bouts of OM are associated with an overall diminished
quality of life [39]. Owing to the multifactorial and polymicrobial
nature of acute, chronic and recurrent OM, this spectrum of
diseases will never be attributed to a single risk factor. However,
gaining a better understanding of the specific risk factors which
predispose a child to recurrent episodes of OM would significantly
improve our ability to diagnose and design medical interventions
to proactively manage this prevalent pediatric disease and thereby
lessen the enormous associated socioeconomic burden. Due to our
interest in the polymicrobial nature of OM, as well as the fact that
colonization of the NP is the first step in the disease process [40],
we decided to further investigate risk factors which may help shape
NP colonization patterns in children, particularly those deemed
OM-prone.
Children are colonized by various bacteria early in life [41,42].
Among those known to colonize the pediatric NP early, S.
pneumoniae, M. catarrhalis and NTHI are of critical import to our
understanding of OM pathogenesis. By age 1, up to 54% of
children are colonized with S. pneumoniae, 74% with M. catarrhalis
and 33% with NTHI [43]. However, it is also known that the
presence or absence of specific members of the NP microbiota has a
direct impact on the incidence of OM [41,44,45] and further, that
host factors, including relative expression of innate immune
effectors such as defensins, may shape the microbial ecology of
commensal organisms [17]. Pettigrew and colleagues [46]
demonstrated an increased incidence of H. influenzae colonization
among children with episodic OM as well as a negative association
between S. pneumoniae and H. influenzae colonization, which has also
been observed by Casey et al. [47]. Moreover, a negative
relationship between S. pneumoniae colonization and bacterial
diversity within the NP during OM has been shown and likewise,
specific bacterial colonization patterns have been associated with
risk of OM [48] Thus, the specific makeup of commensal
organisms within the NP micro-environment is likely playing an
important role in establishing differential susceptibility to infec-
tious diseases of the airway.
As bacterial invasion of the middle ear from the NP is often
triggered by a previous or ongoing viral URT infection [49], it is
also important to consider the effects that viral co-infection have
on NP colonization. We showed, in an animal model of OM, that
one mechanism which facilitates invasion of the middle ear by
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NTHI is viral dysregulation of host defensin expression. Further,
neutralization of beta-defensin led to increased NTHI bacterial
load within the chinchilla NP [23]. Collectively, considering that:
1) the composition of bacteria resident within the pediatric NP is
associated with risk of OM; 2) URT viral infection is coincident
with development of bacterial OM; 3) viral predisposition to
bacterial invasion of the middle ear can be mediated by
dysregulation of expression of innate immune effectors; and 4)
dysregulated expression of even a single AP can lead to an
increased bacterial load in the NP, we sought to investigate
whether genetic polymorphisms in beta-defensins contributed to
susceptibility to OM. Here, we tested if polymorphism in the copy
number of the beta defensin gene cluster on chromosome 8pwas
associated with proneness to OM, perhaps via influence on
composition of bacteria colonizing the pediatric NP.
Overall, when comparing control subjects to a group defined as
‘OM prone’, we observed no direct association with DEFB-CN.
However, DEFB-CN was associated with composition of the NP
microbiota with regard to the three predominant pathogens of
OM. Thus, our data revealed an underlying genetic mechanism
for OM proneness via imparted NP colonization patterns. Sixty-
eight percent of all OM prone children were culture positive for
concurrent colonization by the three predominant pathogens of
OM, whereas only 32% percent of controls were so colonized,
suggesting an important role for this specific NP colonization
pattern with regards to OM proneness. Our data suggested that a
DEFB-CN less than 4 increased the risk for concurrent NTHI, S.
pneumoniae and M. catarrhalis colonization, as well as dual
colonization by either NTHI and M. catarrhalis or NTHI and S.
pneumoniae. Such colonization patterns were directly linked to OM
proneness. These data are in line with earlier reports wherein
simultaneous colonization by multiple pathogens of acute OM was
associated with a greater risk of disease than was colonization by a
single pathogen [50,51]. With regard to our data, whereas
DEFB103 is part of the gene cluster we analyzed for relative copy
number, and thus hBD-3 is implicated in the biology described
here, we cannot exclude important contributions by DEFB4 or
another defensin encoded in the repeat unit.
OM prone children were also four times as likely to be colonized
with NTHI, supporting previously published studies which found
similar associations during URT infections. Also, we observed a
decrease in colonization by S. pneumoniae relative to NTHI among
OM prone subjects. It is theorized this trend is possibly due to
recent antibiotic use within this subset of children [52]. Given that
OM prone children in our study were recruited at the time of
tympanometry tube insertion, these data fit well with such a
hypothesis. In totality, our data not only support published
findings demonstrating that the composition of microbiota within
the NP has significant bearing on susceptibility to URT infections,
including OM in children, but identify a genetic factor that
underlies the composition of bacteria within this anatomical niche,
specifically with regard to the predominant pathogens of OM. As
such, our data further support the notion for dual roles among
defensins in human health; namely, antimicrobial activity against
pathogenic organisms, as well as active management of the
microbial ecology of commensals [17,53].
To the best of our knowledge, this is the first example of an
association between DEFB-CN and three members of the
colonizing bacterial microbiota within a specific anatomic niche,
here the pediatric nasopharynx. The implication being that
prospective determination of a child’s DEFB-CN, together with
identification of other OM risk factors, could provide an
opportunity for a personalized approach to medical management
of OM in childhood, perhaps leading to more rational use of
antibiotics and reduced need for costly and painful surgical
intervention associated with this highly prevalent pediatric
infectious disease.
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